Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-882
Closed -$213K 95
2023
Q1
$213K Hold
882
0.04% 87
2022
Q4
$232K Sell
882
-10
-1% -$2.68K 0.06% 86
2022
Q3
$201K Buy
892
+10
+1% +$2.42K 0.04% 93
2022
Q2
$215K Sell
882
-1,619
-65% -$397K 0.06% 80
2022
Q1
$605K Buy
+2,501
New +$575K 0.06% 65
2019
Q2
Sell
-48,406
Closed -$9.2M 92
2019
Q1
$9.2M Buy
48,406
+2,968
+7% +$567K 2.92% 16
2018
Q4
$8.85M Sell
45,438
-25,243
-36% -$4.92M 3.44% 12
2018
Q3
$14.7M Buy
70,681
+4,076
+6% +$803K 2.1% 26
2018
Q2
$12.3M Sell
66,605
-766
-1% -$135K 1.93% 30
2018
Q1
$11.5M Buy
67,371
+499
+0.7% +$91.6K 1.82% 34
2017
Q4
$11.6M Buy
66,872
+1,665
+3% +$295K 1.77% 34
2017
Q3
$12.2M Buy
65,207
+8
+0% +$1.42K 1.96% 22
2017
Q2
$11.2M Sell
65,199
-3,269
-5% -$532K 1.83% 23
2017
Q1
$11.2M Buy
68,468
+692
+1% +$115K 1.97% 14
2016
Q4
$9.91M Buy
67,776
+147
+0.2% +$22.1K 1.93% 19
2016
Q3
$11.3M Sell
67,629
-768
-1% -$130K 2.21% 8
2016
Q2
$10.4M Buy
68,397
+2,862
+4% +$445K 2.15% 15
2016
Q1
$9.83M Sell
65,535
-1,201
-2% -$178K 2.53% 10
2015
Q4
$10.8M Buy
66,736
+282
+0.4% +$44.3K 2.31% 7
2015
Q3
$10.5M Buy
66,454
+3,092
+5% +$487K 2.47% 6
2015
Q2
$9.73M Buy
63,362
+2,903
+5% +$465K 1.99% 10
2015
Q1
$9.66M Buy
60,459
+2,042
+3% +$322K 2.08% 6
2014
Q4
$9.3M Buy
58,417
+52,927
+964% +$8.25M 1.99% 6
2014
Q3
$771K Sell
5,490
-100
-2% -$13.1K 0.17% 92
2014
Q2
$662K Hold
5,590
0.16% 87
2014
Q1
$689K Buy
5,590
+2,376
+74% +$288K 0.17% 89
2013
Q4
$367K Hold
3,214
0.09% 113
2013
Q3
$360K Buy
3,214
+100
+3% +$10.8K 0.1% 109
2013
Q2
$307K Buy
+3,114
New +$323K 0.09% 114

Other funds holding AMGN

Main Street Research's AMGN Position: Q2 2023 in Review

Main Street Research sold out of Amgen (AMGN) in Q2 2023, closing a stake of 882 shares — an estimated $213K sold.

Main Street Research first reported a position in AMGN in Q2 2013 and held it in 29 quarters. The position peaked at $14.7M in Q3 2018. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Main Street Research reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Main Street Research sold 882 Amgen shares in Q2 2023, an estimated $213K.
  • Main Street Research first reported a position in Amgen in Q2 2013 and held it in 29 quarters.
  • Main Street Research's Amgen position peaked at $14.7M in Q3 2018.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Main Street Research's 13F filing for Q2 2023, filed 8 Aug 2023.